Each School recognizes that strategic investment is required to accelerate collaborations and achieve PharmAlliance objectives and priorities. Funding is intended to support the planning and development of education, practice/professional engagement, or research projects/programs consistent with the PharmAlliance mission.
PharmAlliance Research Clusters for Doctoral Training (PARCDT)
PARCDT Q&A Session
2023 Recording available here
PharmAlliance has historically sought to stimulate research collaborations via support for joint research programs across two or three schools for investigator-driven projects. These programs have helped promote collaborations and have generated some external funding applications. In an effort to simultaneously stimulate collaborations in graduate education and research, the Partnership has moved to an alternate method of support based on the three key principles outlined below:
- To support research in targeted research areas of impact: drug discovery and development in antimicrobial resistance; pandemic readiness and responsiveness; science and translational research in neurological and neuropsychiatric disorders; pharmacoepidemiology and population studies related to medicine safety and use; development of biologics (e.g., gene and cellular therapies); novel mRNA therapeutics
- To support PhD student scholarships rather than postdoctoral or research assistant positions
- To ‘cluster’ support within a priority area to provide a linked cohort of PharmAlliance PhD students
We invite you to consider applying for funding via this new approach. Please note the following important dates:
- 29 September 2023 – Accepting applications
- 1/2 November 2023 – Q&A Session (recording link above)
- 29 February 2023 – Applications due
- 29 March 2023 – Award announcement
- 1 April 2023 – Funding available
Early Career Researcher (ECR) Award
PharmAlliance is committed to the support of early career researcher (ECR) career development and to acceleration of research activities in our priority areas. We are now soliciting requests for PharmAlliance Early Career Researcher (ECR) Award applications. Proposed use of funds must benefit at least two of the three PharmAlliance institutions. Though not a requirement, contribution to PharmAlliance priority areas will be viewed favourably in applications.
The award amount requested should reflect the actual cost of the activities, and should not exceed USD $10,000. Awards may be used to support the following:
- Travel – funds may be used to cover travel costs to meet PharmAlliance collaborators to plan or progress a project or learn a technique/skill.
- Research Activities – funds may be used to purchase supplies or services required to progress a collaborative project.
- Other – With appropriate justification, requests can be made for alternative uses of award funds.
Eligibility:
- The awardee must be an ECR, however other participants in the application do not need to be ECRs.
- The awardee must have participated as a presenter in at least one PharmAlliance event. If an applicant has not yet presented in a PharmAlliance event, they must be scheduled to present in an upcoming event. The following events meet this criteria: PharmAlliance Week, ECR Showcase, Visiting Scholar seminars, Graduate Research E-Symposium (if the ECR participated in this event as a moderator OR previously as a student).
Application timeline:
- 12 October – Applications open
- 30 November – Application deadline
- 15 December – Awards announced
- Reports due 12 months post-award announcement